Aramis Biosciences’ $10.5 Million Series A Financing

Wilson Sonsini Goodrich & Rosati advised Aramis Biosciences on the deal.Aramis Biosciences, a clinical-stage immuno-ophthalmology biopharmaceutical company, announced its launch and the completion of a $10.5…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now